Metabolic network as a progression biomarker of premanifest Huntington's disease

Background. The evaluation of effective disease-modifying therapies for neurodegenerative disorders relies on objective and accurate measures of progression in at-risk individuals. Here we used a computational approach to identify a functional brain network associated with the progression of preclin...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of clinical investigation Vol. 123; no. 9; pp. 4076 - 4096
Main Authors Tang, Chris C, Feigin, Andrew, Ma, Yilong, Habeck, Christian, Paulsen, Jane S, Leenders, Klaus L, Teune, Laura K, Oostrom, Joost C.H. van, Guttman, Mark, Dhawan, Vijay, Eidelberg, David
Format Journal Article
LanguageEnglish
Published American Society for Clinical Investigation 01.09.2013
Subjects
Online AccessGet full text

Cover

Loading…